跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,617 条关于
“Exome Asset Management”
全部
26,617
临床试验
17,049
药物
141
机构
228
资讯
9,199
去年
I-Mab Raises $65 Million to Advance Givastomig Phase 2 Trial for Gastric Cancer
去年
Everest Medicines Invests $30.9M in I-Mab Following Promising 83% Response Rate for Gastric Cancer Bispecific Antibody
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
去年
Exome Sequencing Reveals Missed Hereditary Cancer Risks in Mayo Clinic Study
3个月前
Rare Okur-Chung Neurodevelopmental Syndrome Diagnosed in Singapore Toddler via Whole Exome Sequencing
去年
Largest Whole-Exome Sequencing Study Uncovers New Genetic Links to Epilepsy Subtypes
去年
FDA Approves First Simultaneous Whole Exome and Transcriptome Cancer Test for Precision Oncology
去年
Whole-Exome Sequencing Boosts Diagnosis of Rare Diseases in Czech Children
去年
Norstella Launches NorstellaLinQ, an Integrated Data Asset for Biopharma
2个月前
Qatar's HMC Launches In-House Whole Exome Sequencing, Expands Precision Medicine with 20 Million Annual Diagnostic Tests
第 1 页,共 920 页
上一页
下一页